Procyon Private Wealth Partners »

Regeneron Pharmaceuticals shares owned by Procyon Private Wealth Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Procyon Private Wealth Partners from 13F filings

Historical chart of Procyon Private Wealth Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Procyon Private Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Procyon Private Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 3.5k 962.49
2023-12-31 $2.8M 3.2k 878.29
2023-09-30 $2.5M 3.0k 822.96
2023-06-30 $868k 1.2k 718.54
2020-06-30 $28k 45 622.22
2020-03-31 $22k 45 488.89
2019-12-31 $17k 45 377.78

More positions owned by Procyon Private Wealth Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
American Centy Etf Tr Us Quality Grow (QGRO)
Spdr Ser Tr Portfolio Crport (SPBO)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Pacer Us Small (CALF)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard Index Fds Growth Etf (VUG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Meta Platforms Cl A (META)
Vanguard Whitehall Fds High Div Yld (VYM)
JPMorgan Chase & Co. (JPM)

View all positions for Procyon Private Wealth Partners

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals